KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,519,960 | -19.2% | 210,065 | +3.7% | 0.01% | -11.1% |
| Q2 2023 | $43,934,053 | +10.0% | 202,601 | -7.9% | 0.01% | 0.0% |
| Q1 2023 | $39,942,967 | -6.1% | 219,902 | +1.6% | 0.01% | -10.0% |
| Q4 2022 | $42,522,209 | -13.6% | 216,398 | -1.1% | 0.01% | -16.7% |
| Q3 2022 | $49,215,000 | +47.2% | 218,802 | -17.2% | 0.01% | +50.0% |
| Q2 2022 | $33,442,000 | +24.6% | 264,339 | +24.9% | 0.01% | +60.0% |
| Q1 2022 | $26,839,000 | +125.2% | 211,678 | +132.7% | 0.01% | +150.0% |
| Q4 2021 | $11,917,000 | +8.9% | 90,969 | +1.7% | 0.00% | 0.0% |
| Q3 2021 | $10,941,000 | +18.0% | 89,439 | +10.0% | 0.00% | 0.0% |
| Q2 2021 | $9,269,000 | +26.2% | 81,317 | +33.1% | 0.00% | 0.0% |
| Q1 2021 | $7,343,000 | +11.4% | 61,078 | -5.8% | 0.00% | +100.0% |
| Q4 2020 | $6,590,000 | +28.0% | 64,869 | -2.6% | 0.00% | 0.0% |
| Q3 2020 | $5,150,000 | -35.6% | 66,607 | -7.2% | 0.00% | -50.0% |
| Q2 2020 | $8,003,000 | +100.9% | 71,805 | +29.8% | 0.00% | +100.0% |
| Q1 2020 | $3,983,000 | +32.9% | 55,308 | +39.0% | 0.00% | 0.0% |
| Q4 2019 | $2,998,000 | +1477.9% | 39,800 | +241.6% | 0.00% | – |
| Q3 2019 | $190,000 | – | 11,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |